Skip To Main Content
Deborah Barkauskas on Muck Rack

Deborah Barkauskas

As seen in: Science Magazine, The Journal of Clinical Investigation, Molecular Cancer Research, The Journal of Immunology
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work. Claim your profile

Get in touch with Deborah

Contact Deborah, search articles and posts on X, monitor coverage, and track replies from one place.

Learn more about Muck Rack

Actions

Share this page

Is this you?

As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile

Articles

NK cell heparanase controls tumor invasion and immune surveillance

|
By Eva M. Putz, Alyce J. Mayfosh, Kevin Kos, Deborah Barkauskas
| The Journal of Clinical Investigation
Original citation: J Clin Invest. 2017;127(7):2777–2788. https://doi.org/10.1172/JCI92958 Citation for this retraction: J Clin Invest. 2024;134(13):e183295. https://doi.org/10.1172/JCI183295 QIMR Berghofer Medical Research Institute recently notified the JCI of concerns regarding Figure 3C and Supplemental Figure 4A and indicated that an independent panel investigation concluded that these figures are based on data fabricated by Mark J. Smyth.
Open in Who Shared View Duplicates (2) Issue with article?

SOX9 Defines Distinct Populations of Cells in SHH Medulloblastoma but Is Not Required for Math1-Driven Tumor Formation

|
By Christelle Adolphe, Amanda Millar, Marija Kojic, Deborah Barkauskas
| Molecular Cancer Research Verified
Cancer Genes and Networks Christelle Adolphe, Amanda Millar, Marija Kojic, Deborah S. Barkauskas, Anders Sundström, Fredrik J. Swartling, Soroor Hediyeh-zadeh, Chin Wee Tan, Melissa J. Davis, Laura A. Genovesi and Brandon J. Wainwright DOI: 10.1158/1541-7786.MCR-21-0117 Published November 2021 This article requires a subscription to view the full text. You may purchase access to this article or login to access your subscription using the links below.
Open in Who Shared Issue with article?

NK cell heparanase controls tumor invasion and immune surveillance

|
By Eva M. Putz, Alyce J. Mayfosh, Kevin Kos, Deborah Barkauskas
| The Journal of Clinical Investigation
Abstract NK cells are highly efficient at preventing cancer metastasis but are infrequently found in the core of primary tumors. Here, have we demonstrated that freshly isolated mouse and human NK cells express low levels of the endo-β-D-glucuronidase heparanase that increase upon NK cell activation. Heparanase deficiency did not affect development, differentiation, or tissue localization of NK cells under steady-state conditions.
Open in Who Shared Issue with article?
See all 6 articles